G. Laumond

发表

Synthesis of prodrug-type anti-HIV agents conjugating a REVERSE transcriptase inhibitor to a HIV-1 integrase inhibitor by a spontaneously cleavable linker

Anh Vu, A. Aubertin, I. Zarafu, 2007, Journal of enzyme inhibition and medicinal chemistry.

Stimulation of HIV-1 Replication in Immature Dendritic Cells in Contact with Primary CD4 T or B Lymphocytes

A. Aubertin, C. Moog, V. Holl, 2010, Journal of Virology.

Broadly Neutralizing Antibody VRC01 Prevents HIV-1 Transmission from Plasmacytoid Dendritic Cells to CD4 T Lymphocytes

B. Su, C. Moog, S. Schmidt, 2014, Journal of Virology.

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity

S. Zolla-Pazner, S. Bahram, J. Klingler, 2017, Scientific Reports.

Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production

B. Su, C. Moog, V. Holl, 2014, Scientific Reports.

Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes.

B. Su, C. Moog, V. Holl, 2012, Blood.

Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity

J. A. Gavira, A. Cámara-Artigas, F. Conejero-Lara, 2022, International Journal of Biological Macromolecules.

HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies

N. Salomé, S. Bahram, B. Su, 2018, AIDS.

SYNTHESIS AND ANTI-HIV ACTIVITY OF [D4U]-[TROVIRDINE ANALOGUE] AND [D4T]-[TROVIRDINE ANALOGUE] HETERODIMERS AS INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE

A. Aubertin, A. Ciurea, C. Fossey, 2002, Nucleosides, nucleotides & nucleic acids.

Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies

M. M. Amiri, A. Zarnani, J. Khoshnoodi, 2022, Frontiers in Medicine.

Syntheses of new difluoromethylene benzoxazole and 1,2,4-oxadiazole derivatives, as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

W. R. Dolbier, M. Médebielle, A. Aubertin, 2005 .

Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.

B. Su, C. Moog, S. Schmidt, 2015, AIDS research and human retroviruses.

Synthesis of Certain Heterodimers Expected as HIV-1 Reverse Transcriptase Inhibitors

A. Aubertin, C. Fossey, D. Ladurée, 2003, Nucleosides, nucleotides & nucleic acids.

Dendritic Cell-Lymphocyte Cross Talk Downregulates Host Restriction Factor SAMHD1 and Stimulates HIV-1 Replication in Dendritic Cells

B. Su, C. Moog, M. Lambotin, 2014, Journal of Virology.

Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins

F. Conejero-Lara, C. Moog, G. Laumond, 2022, International journal of molecular sciences.

Characterization of the interaction between the HIV-1 Gag structural polyprotein and the cellular ribosomal protein L7 and its implication in viral nucleic acid remodeling

E. Réal, J. Darlix, Y. Mély, 2016, Retrovirology.

Synthesis and Antiviral Evaluation of Azt Analogues with A Spacer Arm Between Glucidic and Base Moieties. Part II

P. Krausz, A. Aubertin, Vincent Roy, 2007, Nucleosides, nucleotides & nucleic acids.

Synthesis and anti-HIV evaluation of water-soluble calixarene-based bithiazolyl podands.

A. Aubertin, J. Regnouf-de-Vains, G. Laumond, 2010, Bioorganic & Medicinal Chemistry.

Synthesis of 5-alkynylated d4T Analogues as Potential HIV-1 Reverse Transcriptase Inhibitors

A. Ciurea, C. Fossey, D. Ladurée, 2004, Journal of enzyme inhibition and medicinal chemistry.

Synthesis and antiviral activity of aryl phosphoramidate derivatives of β-D- and β-L-C-5-Substituted 2’,3’-didehydro-2’,3’-dideoxy-uridine bearing linker arms

A. Aubertin, C. Fossey, D. Ladurée, 2005, Journal of enzyme inhibition and medicinal chemistry.

8-Modified-2′-Deoxyadenosine Analogues Induce Delayed Polymerization Arrest during HIV-1 Reverse Transcription

Roland Marquet, Johnson Mak, C. Isel, 2011, PloS one.

Synthesis and Anti-HIV Activity of Some Heterodimers [NRTI]-Glycyl-Succinyl-[Trovirdine Analogue] of Known HIV-1 Reverse Transcriptase Inhibitors

A. Aubertin, C. Fossey, D. Ladurée, 2003, Journal of enzyme inhibition and medicinal chemistry.

Synthesis and anti-HIV evaluation of hybrid-type prodrugs conjugating HIV integrase inhibitors with d4t by self-cleavable spacers containing an amino acid residue

Anh Vu, A. Aubertin, I. Zarafu, 2007, Journal of enzyme inhibition and medicinal chemistry.

New Acyclonucleosides: Synthesis and Anti-HIV Activity

P. Krausz, A. Aubertin, R. Zerrouki, 2005, Nucleosides, nucleotides & nucleic acids.

In cell mutational interference mapping experiment (in cell MIME) identifies the 5′ polyadenylation signal as a dual regulator of HIV-1 genomic RNA production and packaging

Pierre B. Cattenoz, F. Jossinet, R. Smyth, 2018, Nucleic acids research.

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

Daniel M. Lidar, J. Gulcher, J. Casanova, 2021, Science Translational Medicine.

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection

N. Paul, A. Samri, B. Autran, 2017, EBioMedicine.

Translational regulation of APOBEC3G mRNA by Vif requires its 5′UTR and contributes to restoring HIV-1 infectivity

J. Batisse, Santiago Guerrero, R. Marquet, 2016, Scientific Reports.

Probing vulnerability of the gp41 C-terminal heptad repeat as target for miniprotein HIV inhibitors.

Bertrand Morel, F. Conejero-Lara, C. Moog, 2020, Journal of molecular biology.

Evaluation of Anti-HIV-1 Mutagenic Nucleoside Analogues*

C. Isel, R. Smyth, V. Vivet-Boudou, 2014, The Journal of Biological Chemistry.

Efficient transfer of HIV-1 in trans and in cis from Langerhans dendritic cells and macrophages to autologous T lymphocytes

B. Su, C. Moog, V. Holl, 2014, AIDS.

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity

S. Zolla-Pazner, S. Bahram, J. Klingler, 2017, Scientific Reports.

Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains

N. Paul, L. Meyer, S. Bahram, 2022, AIDS.

Distinct antibody profiles in HLA-B∗57+, HLA-B∗57− HIV controllers and chronic progressors

N. Paul, B. Autran, O. Lambotte, 2021, AIDS.

Synthesis and Anti-HIV Activity of Some [Nucleoside Reverse Transcriptase Inhibitor]-C5′-Linker-[Integrase Inhibitor] Heterodimers as Inhibitors of HIV Replication

A. Aubertin, C. Fossey, D. Ladurée, 2004, Journal of enzyme inhibition and medicinal chemistry.

Identification of driver genes for severe forms of COVID-19 in a deeply phenotyped young patient cohort

J. Gulcher, J. Casanova, S. Mayeur, 2021, medRxiv.